IDT Australia Limited (ASX:IDT)

David Sparling
CEO
Market Cap (AUD): 39M
Sector: Health Care
Last Trade (AUD): 0.16 +-0 (+-3.03%)
Tab Bar

1. About

IDT specialise in high containment, high potency manufacture of API and finished dose products (including beta-lactams), microbiological and analytical testing, clinical packaging, and pharmacy services.

From initial drug development to clinical trials, IDT is the partner of choice for pharmaceutical companies worldwide, including Pfizer, Johnson & Johnson, Roche, Teva, and Bayer.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk